Ovascience (OVAS) Reports In-Line Q2 EPS

Ovascience (NASDAQ: OVAS) reported Q2 EPS of ($0.64), in-line with the analyst estimate of ($0.64).

For earnings history and earnings-related data on Ovascience (OVAS) click here.

You May Also Be Interested In

• SanDisk and Micron surge as Apple confirms memory price pass-through
• Pfizer reafffirms 2026 guidance after CFO transition announcement
• Citi sees this stock as primary lithium demand beneficiary, upgrades to Buy